Healing Period Pains with Omega-3s
Severe period cramps are not something women should have to live with. Learn how prostaglandins drive menstrual pain, and how omega-3 fatty acids (EPA and DHA) help resolve the inflammation behind dysmenorrhea.
Dr. Abrar Al-Shaer, PhD, RD ·
A note on this article: This piece was originally written for fellow healthcare providers, so it uses more advanced clinical and biochemical language than our usual patient-facing posts. Patients are very welcome to read it, just know it was written with clinicians in mind.
Most women have probably experienced period cramps to some degree. Some more severely than others. But what makes each woman’s period experiences different? Why are we seeing a surge of period issues and debilitating period pains each generation? To answer those questions, we need to first understand what the body is trying to communicate through menstrual pains.
Menstrual cramps are not just surface-level discomforts; they are a sign of deeper physiological processes, particularly inflammation. Just as recurring ear pain would prompt concern and getting treatment, persistent menstrual pain should be treated with the same seriousness. Unfortunately, the cultural normalization of period pain as “just part of being a woman” often results in women not receiving the care they need. We often hear similar statements from other allied health professionals, further perpetuating this incorrect notion.
This often leads to undertreatment, leaving many women to suffer unnecessarily and search for answers online. As integrative and functional Registered Dietitian Nutritionists (RDNs), especially those practicing integrative and functional nutrition, it is our responsibility to help patients understand that severe menstrual pain is not something they should have to live with and that it can often be mitigated with appropriate dietary and lifestyle interventions.
First, it’s crucial to differentiate between what is considered normal and what might signal a deeper issue. In the clinical setting, dysmenorrhea, defined as painful menstruation, is classified into two types: primary and secondary.
Primary vs secondary dysmenorrhea: what is the difference?
Primary dysmenorrhea is characterized by pain that typically begins within 24 hours before menstruation and can last up to 72 hours [1]. These cramps result from the natural contraction of the uterine muscles when our body is ready to shed its uterine lining [1]. Importantly, the pain should be manageable without requiring recurring use of pain medications (or any at all really), and it should not severely disrupt daily activities. If a woman’s period cramps are rated as a 2 or 3 out of 10, she doesn’t need pain meds, can manage with a heat pad when needed, and can do her daily living activities without much issue, this is considered within the realm of “normal” period pain [2].
In contrast, secondary dysmenorrhea is associated with an underlying reproductive health disorder. This type of pain may start well before the 24-hour window of menstruation and extend beyond the 72-hour window (first 3 days of the period) [1]. Conditions such as endometriosis, fibroids, adenomyosis, ovarian cysts, or pelvic inflammatory disease (PID) are common culprits [1]. Unlike primary dysmenorrhea, secondary dysmenorrhea often necessitates medical intervention and can significantly interfere with a woman’s quality of life. In the realm of dietetics, I recommend that you leave the treatment of secondary dysmenorrhea to RDs whose specialties are gynecology and women’s health, since these conditions have so many intricacies. On the other hand, all RDNs should be equipped to support our patients with primary dysmenorrhea.
So, let’s dive in. First, it’s important to note that primary dysmenorrhea indicates an imbalance in the body, particularly in inflammatory pathways. Hormone imbalances are rarely to blame, despite such common claims by social media influencers.
Why Do Period Cramps Happen? The Inflammatory Roots of Dysmenorrhea
The Science Behind Menstrual Pain
Period cramps are primarily driven by the synthesis of prostaglandins, which are lipid compounds that have many effects in the body [3]. Their main job is to signal inflammation. Prostaglandins are produced in many areas of the body when we need an inflammation red flag to be posted, but they are also created in the endometrial lining of the uterus! Prostaglandins play a crucial role in triggering the uterine muscle contractions that help shed the uterine lining during menstruation [3]. Without prostaglandins telling the uterine muscle to contract, the uterus would never be able to shed its lining. However, when prostaglandins are produced in excess, particularly prostaglandin E2 (PGE2), they lead to more intense uterine contractions, increased inflammation, and subsequently, more severe pain [3]. In a nutshell, the more prostaglandins that are made, the more severe the period cramps.
The Origin Story Behind Prostaglandins
To understand the role of inflammation in period pain, we need to delve into the biochemistry of prostaglandin synthesis a bit. At the end of every woman’s cycle there is a large drop in progesterone, which signals to the body that pregnancy did not occur and that the uterine lining must shed. But the only way to shed that uterine lining is to make the uterine muscle contract. So how do we get it to contract? Through the help of prostaglandins! But how do the prostaglandins make it to inside the uterus to begin with? The amazing thing is that after ovulation, the cell membranes of the uterine lining store arachidonic acid inside of them [3]. Arachidonic acid is a type of omega-6 fatty acid and the primary ingredient needed to make prostaglandins later in the cycle. Remember, we need prostaglandins to make the uterine muscle contract and release the uterine lining if pregnancy doesn’t happen.
In summary, a drop in progesterone triggers the release of arachidonic acid from the cell membranes of the uterine lining [3]. This free arachidonic acid is then metabolized by the enzymes cyclooxygenase (COX) and lipoxygenase (LOX) into prostaglandins [4]. The prostaglandins then make the uterine muscles contract and shed the lining, hence the period [3].
Prostaglandin E2 (PGE2), one of the key prostaglandins involved in dysmenorrhea, is particularly pro-inflammatory. It not only increases the intensity and frequency of uterine contractions but also promotes vasoconstriction, leading to the ischemic pain that characterizes severe menstrual cramps. Moreover, PGE2 can exacerbate systemic inflammatory symptoms such as nausea, vomiting, headaches, and even diarrhea, which many women experience alongside their menstrual cramps [3,5,6].
The standard American diet, which is high in omega-6 fatty acids, exacerbates this inflammatory pathway. Omega-6 fatty acids, prevalent in many processed foods, are converted into arachidonic acid, which serves as the precursor for pro-inflammatory prostaglandins like PGE2 [7]. This overabundance of omega-6, coupled with a relative deficiency in omega-3 fatty acids, creates an environment ripe for heightened menstrual pain [3].
Therefore, it is crucial to understand that period cramps are not an isolated event. They are part of a broader picture of systemic inflammation in the body. Just as joint pain or chronic headaches can signal an underlying inflammatory condition, severe menstrual cramps are another form of the body’s inflammatory response. This systemic perspective helps us see that addressing period pain goes beyond just treating the symptoms, and it requires us to tackle the root cause of inflammation itself.
Treating Period Pains: The Power of Omega-3 Fatty Acids
Omega-3s: Nature’s Inflammation Resolution Agents
In our practice, we have treated hundreds of cases of dysmenorrhea, with a particular focus on the role of omega-3 fatty acids in managing period pain. Omega-3s, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are well known for their inflammation-resolving properties. And I say inflammation “resolving” because the notion of “anti” inflammation is not very accurate [7-9]. Technically, EPA and DHA are not halting or stopping inflammation like medications do [8]. They aren’t “suppressing,” but rather they are “addressing” the inflammation [10,11]. The way they are doing this is by directly changing the levels and types of prostaglandins that are being made and altering the biochemical synthesis of pro-inflammatory cytokines [10-12]. They are helping the inflammation reprogram itself, hence the word “resolving” is more accurate than “anti” inflammatory [8]. EPA and DHA work by competing with omega-6 fatty acids for the same enzymes, specifically COX and lipoxygenase (LOX), that are involved in the production of the pro-inflammatory prostaglandins [7].
When omega-3s are present in sufficient quantities, they shift the production of PGE2 and other pro-inflammatory mediators to gentler prostaglandins like Prostaglandin E3 (PGE3) [7,13]. PGE3 helps to instead clear out inflammatory cytokines and “resolve the inflammation.” Think of it like a balancer for the PGE2 [13]. PGE2 adds fuel to the fire of inflammation, whereas PGE3 helps to add some cool water to keep the inflammation controlled and balanced. This helps to dampen inflammation and reduce pain. This biochemical shift is crucial in managing dysmenorrhea, as it directly addresses the inflammatory process that drives period pain.
Clinical Evidence Supporting Omega-3s for Dysmenorrhea
The clinical evidence supporting the use of omega-3 fatty acids for dysmenorrhea is robust. Multiple systematic reviews and meta-analyses have confirmed that omega-3 supplementation can significantly reduce the severity of menstrual cramps [14,15]. For instance, a comprehensive systematic review of randomized controlled trials found that women who took omega-3 supplements experienced a significant reduction in both the intensity and duration of their menstrual pain compared to those who did not [14]. In addition, another study that compared fish oil to ibuprofen found that “the efficacy of fish oil is better than ibuprofen on treatment of severe pain in primary dysmenorrhea” [16].
The mechanism behind this relief is tied directly to the modulation of prostaglandin production. By increasing omega-3 intake, we can reduce the levels of PGE2 in the uterus and increase PGE3 instead, thereby lowering the intensity of uterine contractions and the associated pain [14-16].
Dosage and Supplementation Guidelines
Based on both clinical studies and practice-based evidence, we have found that a daily dose of 2000 mg of combined EPA and DHA is generally effective for most women [14,16]. However, individual needs can vary, with some women benefiting from doses of 1000 mg and others requiring up to 4000 mg for optimal relief [16].
When recommending omega-3 supplements, it is crucial to ensure that the majority of the dosage comes from EPA and DHA rather than other omega-3 sources. Alpha-linolenic acid (ALA) only has a 4% to 8% conversion rate to DHA and EPA, which are the most biochemically active forms of omega-3s [7,17,18]. Unfortunately, many over-the-counter supplements are labeled as “2000 mg of fish oil” or “2000 mg omega-3s” which is misleading because that might not equate to a majority of the omega-3 oil from EPA and DHA. It is essential to read labels carefully and choose high-quality supplements that provide a clear breakdown of their EPA and DHA content. Ideally, EPA and DHA content should make up at least 75% of the supplement. For example, a 2000 mg fish oil product should contain at least 1500 mg from DHA and EPA.
Additionally, the quality of the supplement matters. Omega-3 fatty acids are prone to oxidation, which can reduce their efficacy and even cause harm if consumed in a rancid form. Look for supplements that are formulated with natural antioxidants like tocopherols (vitamin E) or rosemary extract to protect against oxidation. Furthermore, since omega-3 supplements are often derived from fish, it is important to choose products that use low-mercury fish in their formulation, such as sardines or anchovies. Lastly, third-party testing can provide additional assurance of quality.
If someone has a fish allergy or is vegan, they can use algae omega-3s instead, however, amounts may differ. Since the doses of omega-3s are so much less in algae supplements, they will likely need to take more capsules to compensate.
Real-World Applications
In our practice, we have seen numerous cases where omega-3 supplementation has made a significant difference in the management of dysmenorrhea. For example, one patient, a 29-year-old woman with a history of significant primary dysmenorrhea, vomiting, nausea, headaches, and body aches before every period, reported a dramatic reduction in pain after starting a daily regimen of a 2000 mg omega-3 supplement. Over the course of two menstrual cycles, her pain decreased from a 9/10 to a 2/10 on the pain scale, allowing her to discontinue the use of over-the-counter pain medications. She also had 100% resolution of her PMS nausea, vomiting, headaches, and body aches.
Several months later we had an identical case with the same severe PMS symptoms. This patient’s PMS symptoms were so problematic, she would have to take multiple days off work each month. This patient didn’t want to take supplements, though, as she preferred to meet omega-3 needs from food. I was skeptical at first that eating fish would be enough for her given the severity of her symptoms. She would even develop a low-grade fever before each period! But she reassured me that she and her family love seafood and would be able to eat 2 to 3 servings of high omega-3, low-mercury fish per week. So we tried it, and I was shocked. Within just one menstrual cycle, all her symptoms were gone.
Another patient, who initially did not respond to a lower dose of omega-3s, found relief after increasing her intake to 4000 mg per day. These cases highlight the importance of individualized treatment plans and the need for flexibility in dosing.
Don’t Forget the Omega Balancing Act
While increasing omega-3 intake is essential, it is equally important to address the intake of omega-6 fatty acids. The typical American diet has a skewed omega-6 to omega-3 ratio, often around 16:1 or 20:1 [19,20]. This far exceeds the ideal ratio of 4:1 or lower [20]. This imbalance is one of the primary drivers of chronic inflammation, including the inflammation that underlies dysmenorrhea.
Omega-6 fatty acids are found in many processed and refined foods, particularly those made with vegetable oils like corn, soybean, and safflower oil [7]. These oils are commonly used in fried foods, baked goods, and snack foods, making them a ubiquitous part of the modern diet. While omega-6 fatty acids are not inherently harmful and are necessary for health in moderation, their overconsumption leads to an overproduction of pro-inflammatory prostaglandins like PGE2.
Case Study: The Impact of Reducing Omega-6 Intake
We once had a patient who was diligently taking 2000-3000 mg of omega-3s daily but still experienced significant period pain. Upon reviewing her dietary habits, it became clear that she was consuming a high amount of omega-6 fatty acids through frequent restaurant meals and processed snacks. After educating her on the importance of reducing omega-6 intake, she made dietary changes that included cooking more meals at home and choosing whole unprocessed foods more often when eating out.
Within two menstrual cycles, she reported a substantial reduction in pain and other menstrual symptoms. This case underscores the importance of not only increasing omega-3 intake but also actively working to reduce omega-6 consumption to restore a healthy balance and reduce inflammation.
Dietary Strategies for Balancing Omega-3 and Omega-6
To achieve a better omega-3 to omega-6 ratio, patients should be encouraged to increase their consumption of omega-3-rich foods while simultaneously reducing their intake of omega-6-heavy foods. Omega-3-rich fish include fatty fish, which I like to remember with the acronym SMASH: salmon, mackerel (only North Atlantic or Chub variety is low mercury), anchovies, sardines, and herring [21]. Plant-based omega-3 sources like flaxseeds, chia seeds, and walnuts primarily provide ALA, as opposed to DHA or EPA [7,17,18]. And again, the conversion of ALA to EPA/DHA is minimal. Therefore, while these foods are beneficial, they should be supplemented with EPA and DHA from fish or high-quality omega-3 supplements for optimal results. It is also important to encourage patients to cook with oils that are lower in omega-6, such as olive oil or avocado oil, as this can help shift the balance in favor of omega-3s.
Synthetic Birth Control for Symptom Suppression: Pros and Cons
When addressing dysmenorrhea, the use of synthetic birth control is often proposed as a solution for managing period pain. While birth control pills can be helpful in reducing menstrual symptoms, it is important to understand that this approach is primarily symptom-suppressive rather than addressing the root cause of dysmenorrhea. Birth control alters the hormonal landscape by preventing ovulation, which in turn reduces the accumulation of arachidonic acid in uterine cells and subsequently lowers the production of prostaglandins, including prostaglandin E2 (PGE2). This reduction in prostaglandin synthesis can lead to decreased uterine contractions and less pain during menstruation. However, this method does not reprogram the underlying inflammatory processes that contribute to dysmenorrhea; it merely prevents the hormonal trigger that initiates the prostaglandin cascade [1,2,23,25].
While the suppression of symptoms can be sometimes beneficial, particularly in cases of secondary dysmenorrhea where underlying conditions such as endometriosis or fibroids are present, it is important to consider the potential side effects associated with long-term use of synthetic hormones [22-24]. In clinical practice, there may be a rationale for combining birth control with targeted nutrient and herbal therapies to optimize patient outcomes in complex cases of secondary dysmenorrhea [1,26]. However, this combined approach is beyond the scope of this article.
Conclusion: Stop Ignoring Period Pain
Every dietitian should be asking their menstruating patients to rate their period pains, and take that information into account when crafting a plan. Think of it as a vital sign, just like blood pressure, A1c, or lab measures. Period pain can help give you a sneak peek into the patient’s inflammatory profile. Omega-3 supplementation offers a promising and very simple approach to managing dysmenorrhea by directly addressing the inflammatory processes that drive menstrual pain. Even if omega-3s do not eliminate period cramps, any reduction in symptoms is significant as it indicates a decrease in the inflammatory environment within the uterus and pelvic cavity. This can have broader implications for overall health, as reducing chronic inflammation is beneficial for many aspects of well-being.
As RDNs, we are uniquely positioned to educate our patients about the importance of managing period pain through diet and supplementation. By understanding the underlying inflammatory mechanisms and the role of omega-3s, we can offer our patients a safer, more effective treatment option that goes beyond simply masking symptoms with medication. Let’s shift the paradigm that “periods always suck” and empower women to take control of their menstrual health.
This article was originally published in The Integrative RDN (Volume 27, Issue 2), the quarterly newsletter of Dietitians in Integrative and Functional Medicine (DIFM), a dietetic practice group of the Academy of Nutrition and Dietetics (AND).
References
- Smith RP, Kaunitz AM. Dysmenorrhea in adult females: clinical features and diagnosis. UpToDate. Updated April 10, 2024. Accessed August 11, 2024. https://www.uptodate.com/contents/dysmenorrhea-in-adult-females-clinical-features-and-diagnosis
- Romm A. Botanical Medicine for Women’s Health. 2nd ed. Churchill Livingstone; 2017:672.
- Barcikowska Z, Rajkowska-Labon E, Grzybowska ME, Hansdorfer-Korzon R, Zorena K. Inflammatory markers in dysmenorrhea and therapeutic options. Int J Environ Res Public Health. 2020;17(4):1191. doi:10.3390/ijerph17041191
- Astudillo AM, Balgoma D, Balboa MA, Balsinde J. Dynamics of arachidonic acid mobilization by inflammatory cells. Biochim Biophys Acta. 2012;1821(2):249-256. doi:10.1016/j.bbalip.2011.11.006
- Guimarães I, Póvoa AM. Primary dysmenorrhea: assessment and treatment. Rev Bras Ginecol Obstet. 2020;42(8):501-507. doi:10.1055/s-0040-1712131
- Deligeoroglou E. Dysmenorrhea. Ann N Y Acad Sci. 2000;900(1):237-244. doi:10.1111/j.1749-6632.2000.tb06235.x
- Al-Shaer AE, Buddenbaum N, Shaikh SR. Polyunsaturated fatty acids, specialized pro-resolving mediators, and targeting inflammation resolution in the age of precision nutrition. Biochim Biophys Acta Mol Cell Biol Lipids. 2021;1866(7):158936. doi:10.1016/j.bbalip.2021.158936
- Serhan CN, Levy BD. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest. 2018;128(7):2657-2669. doi:10.1172/JCI97943
- Wood D, Ayoub S. Acute and chronic inflammation. In: Serhan C, Ward P, Gilroy D, eds. Fundamentals of Inflammation. Cambridge University Press; 2010.
- Serhan CN, Chiang N, Dalli J. The resolution code of acute inflammation: novel pro-resolving lipid mediators in resolution. Semin Immunol. 2015;27(3):200-215. doi:10.1016/j.smim.2015.03.004
- Serhan CN, Chiang N. Resolution phase lipid mediators of inflammation: agonists of resolution. Curr Opin Pharmacol. 2013;13(4):632-640. doi:10.1016/j.coph.2013.05.012
- Fredman G, Li Y, Dalli J, Chiang N, Serhan CN. Self-limited versus delayed resolution of acute inflammation: temporal regulation of pro-resolving mediators and microRNA. Sci Rep. 2012;2:639. doi:10.1038/srep00639
- Markworth JF, Kaur G, Miller EG, et al. Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid. FASEB J. 2016;30(11):3714-3725. doi:10.1096/fj.201600360R
- Snipe RMJ, Brelis B, Kappas C, et al. Omega-3 long chain polyunsaturated fatty acids as a potential treatment for reducing dysmenorrhoea pain: systematic literature review and meta-analysis. Nutr Diet. 2024;81(1):94-106. doi:10.1111/1747-0080.12835
- Rahbar N, Asgharzadeh N, Ghorbani R. Effect of omega-3 fatty acids on intensity of primary dysmenorrhea. Int J Gynaecol Obstet. 2012;117(1):45-47. doi:10.1016/j.ijgo.2011.11.019
- Zafari M, Behmanesh F, Agha Mohammadi A. Comparison of the effect of fish oil and ibuprofen on treatment of severe pain in primary dysmenorrhea. Caspian J Intern Med. 2011;2(3):279-282.
- Ostermann AI, West AL, Schoenfeld K, et al. Plasma oxylipins respond in a linear dose-response manner with increased intake of EPA and DHA: results from a randomized controlled trial in healthy humans. Am J Clin Nutr. 2019;109(5):1251-1263. doi:10.1093/ajcn/nqz016
- Calder PC. Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochim Biophys Acta. 2015;1851(4):469-484. doi:10.1016/j.bbalip.2014.08.010
- Simopoulos AP. Evolutionary aspects of diet: the omega-6/omega-3 ratio and the brain. Mol Neurobiol. 2011;44(2):203-215. doi:10.1007/s12035-010-8162-0
- DiNicolantonio JJ, O’Keefe J. The importance of maintaining a low omega-6/omega-3 ratio for reducing the risk of autoimmune diseases, asthma, and allergies. Mo Med. 2021;118(5):453-459.
- Mercury in fish. California Office of Environmental Health Hazard Assessment. Accessed August 12, 2024. https://oehha.ca.gov/media/downloads/fish/fact-sheet/hgfactsnontechnical.pdf
- Williams RS. Benefits and risks of oral contraceptive use. Postgrad Med. 1992;92(7):155-171. doi:10.1080/00325481.1992.11701539
- InformedHealth.org [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-. Contraception: hormonal contraceptives. Updated June 29, 2017. Accessed August 12, 2024.
- Wright KP, Johnson JV. Evaluation of extended and continuous use oral contraceptives. Ther Clin Risk Manag. 2008;4(5):905-911.
- Cooper DB, Patel P. Oral contraceptive pills. In: StatPearls. StatPearls Publishing; 2024. Updated February 29, 2024. Accessed August 12, 2024. https://www.ncbi.nlm.nih.gov/books/NBK430882/
- Vercellini P, De Giorgi O, Mosconi P, Stellato G, Vicentini S, Crosignani PG. Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis. Fertil Steril. 2002;77(1):52-61. doi:10.1016/S0015-0282(01)02951-X